Literature DB >> 7530139

Tenascin in connective tissue development and pathogenesis.

E J Mackie1.   

Abstract

The extracellular matrix glycoprotein, tenascin (tenascin-C) is selectively expressed at sites of tissue remodeling in developing and pathological connective tissues, including cartilage, bone, and dermis. Functional studies suggest that tenascin is important for chondrocyte differentiation and feather bud elongation. Tenascin is able to stimulate cell migration and proliferation in some cell types and its tissue distribution is often correlated with these processes. Tenascin is a poor adhesive substratum for cells, and its effects on cell behavior may be mediated by effects on cell shape. In normal adult connective tissues, tenascin is strongly expressed at sites of contact between elements of the musculoskeletal system, suggesting an additional role for tenascin in matrix organization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7530139

Source DB:  PubMed          Journal:  Perspect Dev Neurobiol        ISSN: 1026-7697


  17 in total

1.  Cell-adhesive responses to tenascin-C splice variants involve formation of fascin microspikes.

Authors:  D Fischer; R P Tucker; R Chiquet-Ehrismann; J C Adams
Journal:  Mol Biol Cell       Date:  1997-10       Impact factor: 4.138

2.  Expression of tenascin in joint-associated tissues during development and postnatal growth.

Authors:  E J Mackie; S Ramsey
Journal:  J Anat       Date:  1996-02       Impact factor: 2.610

3.  Does extracellular matrix of the varicose vein wall change according to clinical stage?

Authors:  Mehmet Ali Demirkıran; Cüneyt Köksoy; Aylin Okçu Heper; Uğur Bengisun
Journal:  Ulus Cerrahi Derg       Date:  2014-12-01

4.  Pharmacoproteomic study of three different chondroitin sulfate compounds on intracellular and extracellular human chondrocyte proteomes.

Authors:  Valentina Calamia; Patricia Fernández-Puente; Jesús Mateos; Lucía Lourido; Beatriz Rocha; Eulália Montell; Josep Vergés; Cristina Ruiz-Romero; Francisco J Blanco
Journal:  Mol Cell Proteomics       Date:  2011-12-27       Impact factor: 5.911

5.  The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea.

Authors:  A Tuori; I Virtanen; E Aine; H Uusitalo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-04       Impact factor: 3.117

6.  Ultrastructural morphology and expression of proteoglycans, betaig-h3, tenascin-C, fibrillin-1, and fibronectin in bullous keratopathy.

Authors:  S Akhtar; A J Bron; N R Hawksworth; R E Bonshek; K M Meek
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

7.  Expression of modulators of extracellular matrix structure after anterior cruciate ligament injury.

Authors:  Carla M Haslauer; Benedikt L Proffen; Victor M Johnson; Martha M Murray
Journal:  Wound Repair Regen       Date:  2014 Jan-Feb       Impact factor: 3.617

8.  Laminins, tenascin and type VII collagen in colorectal mucosa.

Authors:  J Lohi; I Leivo; T Tani; T Kiviluoto; E Kivilaakso; R E Burgeson; I Virtanen
Journal:  Histochem J       Date:  1996-06

9.  Integrins in the optic nerve head: potential roles in glaucomatous optic neuropathy (an American Ophthalmological Society thesis).

Authors:  John C Morrison
Journal:  Trans Am Ophthalmol Soc       Date:  2006

10.  Tenascin C in medullary thyroid microcarcinoma and C-cell hyperplasia.

Authors:  Oskar Koperek; Astrid Prinz; Christian Scheuba; Bruno Niederle; Klaus Kaserer
Journal:  Virchows Arch       Date:  2009-05-30       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.